No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve

Neuroscience Letters

Volumn 352, Issue 2, 2003, Pages 93-96

  Quasthoff, Stefan ^a   Pojer, Christine ^a   Mori, Alexander ^a   Hofer, Doris ^a   Liebmann, Peter ^a   Kieseier, Bernd C ^b   Schreibmayer, Wolfgang ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Conduction block; Guillain Barr syndrome; Multiple sclerosis; Na+ channel; Peptide blocker; Rat sural nerve; Xenopus oocytes

Indexed keywords

ANKYRIN; CARRIER PROTEIN; GLUTAMINYLTYROSYLASPARAGINYLALANYLASPARTIC ACID; ISOPROTEIN; PENTAPEPTIDE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMPLITUDE MODULATION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ISOLATED ORGAN; LATENT PERIOD; MALE; MEMBRANE CURRENT; NERVE CONDUCTION; NERVE POTENTIAL; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANVIER NODE; RAT; SURAL NERVE; XENOPUS;

EID: 0242475058     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.029     Document Type: Article

References (18)

1. Aulkemeyer P., Hausner G., Brinkmeier H., Weber F., Wurz A., Heidenreich F., Rudel R. The small sodium-channel blocking factor in the cerebrospinal fluid of multiple sclerosis patients is probably an oligopeptide. J. Neurol. Sci. 172:2000;49-54.
2. Bennett V., Lambert S. Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels. J. Neurocytol. 28:1999;303-318.
3. Bongenhielm U., Nosrat C.A., Nosrat I., Eriksson J., Fjell J., Fried K. Expression of sodium channel SNS/PN3 and ankyrin(G) mRNAs in the trigeminal ganglion after inferior alveolar nerve injury in the rat. Exp. Neurol. 164:2000;384-395.
4. v1.2a subunit of the voltage-dependent sodium channel with nodal ankyrinG. In vitro mapping of the interacting domains and association in synaptosomes. J. Biol. Chem. 277:2002;28996-29004.
5. Brinkmeier H., Aulkemeyer P., Wollinsky K.H., Rudel R. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat. Med. 6:2000;808-811.
6. Cummins T.R., Renganathan M., Stys P.K., Herzog R.I., Scarfo K., Horn R., Dib-Hajj S.D., Waxman S.G. The pentapeptide QYNAD does not block voltage-gated sodium channels. Neurology. 60:2003;224-229.
7. Dascal N., Lotan I., Karni E., Gigi A. Calcium channel currents in Xenopus oocytes injected with rat skeletal muscle RNA. J. Physiol. 450:1992;469-490.
8. Fels G. Tolperisone: evaluation of the lidocaine-like activity by molecular modeling. Arch. Pharm. 329:1996;171-178.
9. Frohnwieser B., Chen L.Q., Schreibmayer W., Kallen R.G. Modulation of the human cardiac sodium channel alpha-subunit by cAMP-dependent protein kinase and the responsible sequence domain. J. Physiol. 498:(Pt 2):1997;309-318.
10. Goldin A.L. Diversity of mammalian voltage-gated sodium channels. Ann. N. Y. Acad. Sci. 868:1999;38-50.
11. Hinck D., Koppenhofer E. Tolperisone - a novel modulator of ionic currents in myelinated axons. Gen. Physiol. Biophys. 20:2001;413-429.
12. Hofmann F., Quasthoff S. No acute effects of GBS cerebrospinal fluid on electrophysiological parameters of peripheral nerves in vitro. J. Neurol. 245:1998;427.
13. Kuwabara S., Yuki N., Koga M., Hattori T., Matsuura D., Miyake M., Noda M. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann. Neurol. 44:1998;202-208.
14. Quasthoff S., Grosskreutz J., Schroder J.M., Schneider U., Grafe P. Calcium potentials and tetrodotoxin-resistant sodium potentials in unmyelinated C fibres of biopsied human sural nerve. Neuroscience. 69:1995;955-965.
15. Sambrook J., Russel D.W. Molecular Cloning - A Laboratory Manual. 3rd Edition:2001;CSH Press, New York.
16. + currents in isolated rat myelinated nerve fibers. Ann. Neurol. 37:1995;436-442.
17. Weber F., Rudel R., Aulkemeyer P., Brinkmeier H. Anti-GM1 antibodies can block neuronal voltage-gated sodium channels. Muscle Nerve. 23:2000;1414-1420.
18. Weber F., Rudel R., Aulkemeyer P., Brinkmeier H. The endogenous pentapeptide QYNAD induces acute conduction block in the isolated rat sciatic nerve. Neurosci. Lett. 317:2002;33-36.